Aram Mangasarian is the CEO of TME Pharma (formerly NOXXON Pharma), a publicly quoted biotechnology company focused on improving cancer treatments.
Aram Mangasarian is the CEO of TME Pharma (formerly NOXXON Pharma), a publicly quoted biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment. He was appointed CEO in July 2015, having previously joined the company as Chief Business Officer in May 2010. Under his leadership, TME Pharma has raised close to €65 million. Prior to TME Pharma, he held leadership roles at Novexel and ExonHit Therapeutics, contributing to significant licensing agreements and acquisitions.
Full founder directory · Investor directory · Company funding database · Fundraising library